Results 81 to 90 of about 28,866 (196)

Detection of Copy‐Number Variations in CNS Tumours From Off‐Target Reads of Hybrid‐Capture Sequencing

open access: yesNeuropathology and Applied Neurobiology, Volume 52, Issue 2, April 2026.
Off‐target sequencing reads from small hybrid‐capture NGS panels can be leveraged to reconstruct genome‐wide copy number variation (CNV) profiles in CNS tumours. Across diverse tumour types, CNV profiles derived from off‐target reads show high concordance with methylation array data and reliably detect clinically relevant arm‐level alterations ...
Jan Schnorrenberg   +7 more
wiley   +1 more source

Electrospun Nanofibres for Load‐Bearing Composite Materials—A Review of Techniques, Mechanical Properties and Durability

open access: yesPolymer Composites, Volume 47, Issue 5, Page 3917-3945, 10 March 2026.
Electrospun nanofibre for load‐bearing composite materials. ABSTRACT Electrospun nanofibres are emerging nanomaterials prized for their scalability, high surface area to volume ratio and yield. Their effectiveness in improving the mechanical properties of fiber reinforced composites is widely reported. Nanofibres could activate multiscale toughness and
Usaid Ahmed Shakil, Petr Hájek
wiley   +1 more source

Neurofibromatosis Type 2 (NF2) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Neurofibromatosis type 2 (NF2), Bilateral acoustic neurofibromatosis, Central neurofibromatosis. OMIM #101000. The correct name for the condition is Neurofibromatosis type 2 (NF2). The remaining names are historically due to the overlap with NF1 and previous confusion over the two conditions. The first clear description of NF2 was in 1822 by Wishart.
openaire   +2 more sources

Interactions among Merlin, Arkadia, and SKOR2 mediate NF2-associated human Schwann cell proliferation

open access: yesStem Cell Research & Therapy
Background NF2-related Schwannomatosis (previously referred to as Neurofibromatosis Type 2, or NF2) is a genetic-associated disease resulting from mutations in the gene, NF2. NF2 encodes the Merlin protein, which acts as a tumor suppressor.
Pei-Ciao Tang   +7 more
doaj   +1 more source

Malignant pleural mesothelioma in a young patient with neurofibromatosis 2 and acquired BAP1 loss: A case report

open access: yesCurrent Problems in Cancer: Case Reports
Introduction: Neurofibromatosis type 2 (NF2) is a rare genetic disorder resulting from germline loss of the NF2 tumor suppressor gene characterized by the development of multiple benign central nervous system tumors.
Jerry Kong   +2 more
doaj   +1 more source

Unraveling a Hidden Mass: A 10‐Year Mystery of Groin Swelling Reveals an Unexpected Diagnosis of Neurofibroma

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
Unravelling a Hidden Mass: Case of 70‐year‐old female presenting with 10‐year history of painless groin swelling. Intraoperative discovery revealed an unexpected neurofibroma. ABSTRACT This case presents the perplexing journey of a 70‐year‐old woman with a decade‐long history of painless, gradually enlarging left‐side groin swelling.
Alaa Tajeldeen Habeeb Abdallah   +6 more
wiley   +1 more source

Clinical diagnosis and treatment of bitaleral acoustic neurofibromatosis type 2: a retrospective analysis of 4 patients [PDF]

open access: yesJichu yixue yu linchuang, 2020
Objective To investigate the diagnosis and treatment of neurofibromatosis type2(NF2). Methods The clinical manifestations, magnetic resonance imaging(MRI) findings, and treatment of 4 patients with surgically and pathologically-confirmed NF2 ...
YANG Chang-li, TU Guo-long, XIA Ying
doaj  

NF2 can mediate the expression of CAMK2A in a tissue specific manner

open access: yesScientific Reports
Meningioma is the most prevalent primary intracranial tumor, with approximately half of patients harboring NF2 alteration. The rationale behind the presence of NF2 alteration in meningiomas and its absence in non-nerve system tumors remains elusive ...
Zhaoying Lei, Huajian Cai, Qingfeng Yan
doaj   +1 more source

CRISPR Enabled Precision Oncology: From Gene Editing to Tumor Microenvironment Remodeling

open access: yesMed Research, Volume 2, Issue 1, Page 106-129, March 2026.
CRISPR technology has progressed from a prokaryotic immune system to a diverse suite of editing platforms, including Cas nucleases, base and prime editors, and RNA‐targeting enzymes. These advances enable precise genomic and epigenomic interventions, high‐throughput functional screening, and immune engineering.
Kailai Li   +8 more
wiley   +1 more source

Cardy states, factorization and idempotency in closed string field theory

open access: yes, 2004
We show that boundary states in the generic on-shell background satisfy a universal nonlinear equation of closed string field theory. It generalizes our previous claim for the flat background.
Asakawa   +58 more
core   +3 more sources

Home - About - Disclaimer - Privacy